HBIOVSMRNA• 28 Days (Normalized)
HBIO vs MRNA (Harvard Bioscience Inc. vs Moderna Inc.)
Showing Closing Date Range from Aug, 19 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HBIO Performance $7.97
+12.57%
Harvard Bioscience Inc.
Normalized Baseline0.00%
MRNA Performance $145.62
-16.49%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin HBIO LEADS
+29.06%
HBIO outperforming by 29.06%
HBIOMRNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HBIO MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | HBIO Price | HBIO Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $7.97 | +12.57% | $145.62 | -16.49% | +29.06% |
| Sep 15, 2026 | $8.00 | +12.99% | $143.77 | -17.55% | +30.54% |
| Sep 14, 2026 | $8.09 | +14.27% | $146.69 | -15.88% | +30.15% |
| Sep 11, 2026 | $8.03 | +13.42% | $143.97 | -17.44% | +30.86% |
| Sep 10, 2026 | $8.15 | +15.11% | $136.62 | -21.65% | +36.76% |
| Sep 09, 2026 | $7.95 | +12.29% | $135.61 | -22.23% | +34.52% |
| Sep 08, 2026 | $7.95 | +12.29% | $140.33 | -19.53% | +31.82% |
| Sep 04, 2026 | $8.02 | +13.28% | $145.55 | -16.53% | +29.81% |
| Sep 03, 2026 | $8.00 | +12.99% | $148.87 | -14.63% | +27.62% |
| Sep 02, 2026 | $8.20 | +15.82% | $150.81 | -13.52% | +29.34% |
| Sep 01, 2026 | $8.04 | +13.56% | $154.27 | -11.53% | +25.09% |
| Aug 31, 2026 | $8.11 | +14.55% | $140.34 | -19.52% | +34.07% |
| Aug 28, 2026 | $7.93 | +12.01% | $137.99 | -20.87% | +32.88% |
| Aug 27, 2026 | $7.90 | +11.58% | $142.77 | -18.13% | +29.71% |
| Aug 26, 2026 | $7.65 | +8.05% | $149.66 | -14.18% | +22.23% |
Page 1 of 2